Cita APA

Brenner, A., Reardon, D., Wen, P., Fox, P., Huang, S., Muzi, M., . . . Lee, E. (2017). ACTR-95. HYPOXIA ACTIVATED EVOPHOSPHAMIDE (TH-302) FOR RECURRENT GBM FOLLOWING BEVACIZUMAB FAILURE, A MULTICENTER PHASE II STUDY. Neuro Oncol.

Chicago Style Citation

Brenner, Andrew, David Reardon, Patrick Wen, Peter Fox, Shiliang Huang, Mark Muzi, Yichu Liu, i Eudocia Lee. "ACTR-95. HYPOXIA ACTIVATED EVOPHOSPHAMIDE (TH-302) FOR RECURRENT GBM FOLLOWING BEVACIZUMAB FAILURE, A MULTICENTER PHASE II STUDY." Neuro Oncol 2017.

Cita MLA

Brenner, Andrew, et al. "ACTR-95. HYPOXIA ACTIVATED EVOPHOSPHAMIDE (TH-302) FOR RECURRENT GBM FOLLOWING BEVACIZUMAB FAILURE, A MULTICENTER PHASE II STUDY." Neuro Oncol 2017.